LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Metrics to compare | LNSR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLNSRPeersSector | |
---|---|---|---|---|
P/E Ratio | −2.7x | −3.6x | −0.5x | |
PEG Ratio | 0.01 | −0.19 | 0.00 | |
Price/Book | −6.9x | 2.5x | 2.6x | |
Price / LTM Sales | 2.7x | 3.7x | 3.3x | |
Upside (Analyst Target) | 15.9% | 25.1% | 43.5% | |
Fair Value Upside | Unlock | 1.6% | 6.3% | Unlock |